发明申请
US20060183665A1 Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension
审中-公开
钾通道调节剂twik-1,任务1 gorl1。 sk2 pr pcn1,用于治疗心律失常,冠心病或高血压
- 专利标题: Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension
- 专利标题(中): 钾通道调节剂twik-1,任务1 gorl1。 sk2 pr pcn1,用于治疗心律失常,冠心病或高血压
-
申请号: US10565185申请日: 2004-07-06
-
公开(公告)号: US20060183665A1公开(公告)日: 2006-08-17
- 发明人: Peter Ellinghaus , Klaus Munter
- 申请人: Peter Ellinghaus , Klaus Munter
- 申请人地址: DE Leverkusen D-51368
- 专利权人: Bayer HealthCare AG
- 当前专利权人: Bayer HealthCare AG
- 当前专利权人地址: DE Leverkusen D-51368
- 优先权: DE10332685.5 20030718
- 国际申请: PCT/EP04/07364 WO 20040706
- 主分类号: A61K38/17
- IPC分类号: A61K38/17
摘要:
The invention relates to the use of modulators of the potassium channels TWIK-1, TASK-1, GIRK1 SK2 and PCN1 for producing a medicament for the treatment and/or prophylaxis of cardiac dysrhythmias (arrhythmias), coronary heart disease, and hypertension.